×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4043019
Return to Previous Page
4043019

Availability: In stock

PAR-4 (1-6) amide (human) trifluoroacetate salt
H-Gly-Tyr-Pro-Gly-Gln-Val-NH₂ trifluoroacetate salt

4043019

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4043019.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 210.00
CHF 195.30 (7%)
4043019.0025 25 mg Ships within 3-5 business days  
CHF 840.00
CHF 781.20 (7%)

Details

GYPGQV-amide, tethered ligand sequence of human PAR-4.
Catalog Number H-6346
APC Number 85-2-08
One Letter Code GYPGQV-NH₂
Synonyms Proteinase Activated Receptor 4 (1-6) amide (human), GYPGQVamide, Coagulation Factor II Receptor-Like 3 (1-6) amide (human), Thrombin Receptor-Like 3 (1-6) amide (human), GYPGQV-NH2 Selective Protease-Activated Receptor 4 (PAR4) Agonist
Molecular Formula C₂₈H₄₂N₈O₈
Relative Molecular Mass 618.69
CAS Registry Number 245443-51-0
Source Synthetic
Storage Conditions -20 ± 5 °C
Application Hematology
Links / Documents:

Bachem product citations

C.Y.Huang et al., Mediators Inflamm., 2013, 326041 (2013)
C.Y.Huang et al., Arthritis Rheum., 64, 3344 (2012)
J.F.Liu et al., Arthritis Res. Ther., 14, R91 (2012)
H.T.Chen et al., J. Cell. Physiol., 223, 737 (2010)
Y.C.Chiu et al., Mol. Immunol., 45, 1587 (2008)

Product citations

M.D.Hollenberg and S.Houle, Swiss Med. Wkly., 135, 425 (2005)
M.Tognetto et al., Br. J. Pharmacol., 139, 21 (2003)
M.D.Hollenberg et al., Can. J. Physiol. Pharmacol., 77, 458 (1999)